1. Home
  2. CCO vs ABCL Comparison

CCO vs ABCL Comparison

Compare CCO & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clear Channel Outdoor Holdings Inc.

CCO

Clear Channel Outdoor Holdings Inc.

HOLD

Current Price

$2.08

Market Cap

1.1B

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$4.41

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCO
ABCL
Founded
1995
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
CCO
ABCL
Price
$2.08
$4.41
Analyst Decision
Hold
Buy
Analyst Count
6
5
Target Price
$2.10
$7.75
AVG Volume (30 Days)
2.6M
3.7M
Earning Date
02-23-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,569,344,000.00
$35,325,000.00
Revenue This Year
$6.76
$25.45
Revenue Next Year
$4.42
$10.07
P/E Ratio
N/A
N/A
Revenue Growth
54.21
7.17
52 Week Low
$0.81
$1.89
52 Week High
$2.26
$6.52

Technical Indicators

Market Signals
Indicator
CCO
ABCL
Relative Strength Index (RSI) 50.53 69.07
Support Level $2.04 $3.34
Resistance Level $2.17 $4.20
Average True Range (ATR) 0.09 0.21
MACD -0.02 0.12
Stochastic Oscillator 20.00 90.56

Price Performance

Historical Comparison
CCO
ABCL

About CCO Clear Channel Outdoor Holdings Inc.

Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: